Metabolic Enzyme Microarray Coupled with Miniaturized Cell-Culture Array Technology for High-Throughput Toxicity Screening

  • Moo-Yeal Lee
  • Jonathan S. Dordick
  • Douglas S. Clark
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 632)

Abstract

Due to poor drug candidate safety profiles that are often identified late in the drug development process, the clinical progression of new chemical entities to pharmaceuticals remains hindered, thus resulting in the high cost of drug discovery. To accelerate the identification of safer drug candidates and improve the clinical progression of drug candidates to pharmaceuticals, it is important to develop high-throughput tools that can provide early-stage predictive toxicology data. In particular, in vitro cell-based systems that can accurately mimic the human in vivo response and predict the impact of drug candidates on human toxicology are needed to accelerate the assessment of drug candidate toxicity and human metabolism earlier in the drug development process. The in vitro techniques that provide a high degree of human toxicity prediction will be perhaps more important in cosmetic and chemical industries in Europe, as animal toxicity testing is being phased out entirely in the immediate future.

We have developed a metabolic enzyme microarray (the Metabolizing Enzyme Toxicology Assay Chip, or MetaChip) and a miniaturized three-dimensional (3D) cell-culture array (the Data Analysis Toxicology Assay Chip, or DataChip) for high-throughput toxicity screening of target compounds and their metabolic enzyme-generated products. The human or rat MetaChip contains an array of encapsulated metabolic enzymes that is designed to emulate the metabolic reactions in the human or rat liver. The human or rat DataChip contains an array of 3D human or rat cells encapsulated in alginate gels for cell-based toxicity screening. By combining the DataChip with the complementary MetaChip, in vitro toxicity results are obtained that correlate well with in vivo rat data.

Key words

Microarray Metabolic enzyme array MetaChip Cell array DataChip High-throughput toxicity screening 

References

  1. 1.
    Furge LL, Guengerich FP (2006) Cytochrome P450 enzymes in drug metabolism and chemical toxicology: an introduction. Biochem Mol Biol Educ 34:66-74PubMedCrossRefGoogle Scholar
  2. 2.
    Guengerich FP (2006) Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J 8:E101-E111PubMedCrossRefGoogle Scholar
  3. 3.
    Zamek-Gliszczynski MJ, Hoffmaster KA, Nezasa K, Tallman MN, Brouwer KLR (2006) Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. Eur J Pharm Sci 27:447-486PubMedCrossRefGoogle Scholar
  4. 4.
    Lee MY, Dordick JS (2006) High-throughput human metabolism and toxicity analysis. Curr Opin Biotech 17:619-627PubMedCrossRefGoogle Scholar
  5. 5.
    Hariparsad N, Sane RS, Strom SC, Desai PB (2006) In vitro methods in human drug biotransformation research: implications for cancer chemotherapy. Toxicol in Vitro 20:135-153PubMedCrossRefGoogle Scholar
  6. 6.
    Brandon EFA, Raap CD, Meijerman I, Beijnen JH, Schellens JHM (2003) An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol Appl Pharmacol 189:233-246PubMedCrossRefGoogle Scholar
  7. 7.
    Gomez-Lechon MJ, Donato MT, Castell JV, Jover R (2004) Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. Curr Drug Metab 5:443-462PubMedCrossRefGoogle Scholar
  8. 8.
    Sivaraman A, Leach JK, Townsend S, Iida T, Hogan BJ, Stolz DB, Fry R, Samson LD, Tannenbaum SR, Griffith LG (2005) A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr Drug Metab 6:569-591PubMedCrossRefGoogle Scholar
  9. 9.
    Hewitt NJ, Lechon MJG, Houston JB, Hallifax D, Brown HS, Maurel P, Kenna JG, Gustavsson L, Lohmann C, Skonberg C, Guillouzo A, Tuschl G, Li AP, LeCluyse E (2007) Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 39:159-234PubMedCrossRefGoogle Scholar
  10. 10.
    Lee MY, Park CB, Clark DS, Dordick JS (2005) Metabolizing enzyme toxicology assay chip (MetaChip) for high-throughput microscale toxicity analyses. Proc Natl Acad Sci USA 102:983-987PubMedCrossRefGoogle Scholar
  11. 11.
    Lee MY, Clark DS, Dordick JS (2006) Human P450 microarrays for in vitro metabolite toxicity analysis: toward complete automation of human toxicology screening. J Assoc Lab Automat 11:374-380CrossRefGoogle Scholar
  12. 12.
    Lee MY, Ramasubramanian AK, Sukumaran SM, Hogg MG, Clark DS, Dordick JS (2008) Three-dimensional cellular array chip for microscale toxicology assay. Proc Natl Acad Sci USA 105:59-63PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Moo-Yeal Lee
    • 1
  • Jonathan S. Dordick
    • 2
  • Douglas S. Clark
    • 3
  1. 1.Solidus Biosciences, Inc.TroyUSA
  2. 2.Department of Chemical and Biological EngineeringRensselaer Polytechnic InstituteTroyUSA
  3. 3.Department of Chemical EngineeringUniversity of CaliforniaBerkeleyUSA

Personalised recommendations